Charged Alpha logo
CHARGED ALPHA
Stock Analysis
Stock Library / CLBT
CLBT Technology Latest YouTube: Q2 2026 Published 2026-08-18

Cellebrite DI Ltd.

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Latest earnings video

CLBT Stock Q2 2026: Cellebrite Earnings - $15M Of ARR, $1.1B Of Market Value

Published 2026-08-18

Library coverage

Episodes tracked
1
Episodes linked
1
Latest video
Q2 2026
2026-08-18
Podcast available
Yes
Current price
$11.05
-0.22 (-1.95%)
Trailing / Forward P/E
48.04x
Forward: 16.92x
Market cap / Volume
Volume:
Revenue / Earnings Growth
15.8%
Earnings: -67.9%
Margins
5.3% op
Gross: 83.0% · Net: 11.4%
Balance sheet
1.62x current
Debt / Equity: 4.3
52-week range / Beta
$9.58 - $19.98
Beta: 1.18
Analyst target
$15.36
Upside: 39.0%
Cash / shareholder return
4.51% FCF yield
Dividend yield: —

Company context

Industry: Software - Infrastructure
Country: Israel
Employees:
Price to book: 5.15x
Return on equity: 12.4%
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

Price chart

Market context for CLBT

Competitive view

CLBT vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

Cellebrite DI Ltd. latest YouTube video thumbnail YouTube
Cellebrite DI Ltd.
CLBT
Latest video
Q2 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Intel Corporation latest YouTube video thumbnail YouTube
Intel Corporation
INTC
Latest video
Q2 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Profitability is serviceable, but it does not obviously dominate peers on margin or cash conversion alone.
Valuation already asks investors to pay up, so the upside case depends on continued execution staying strong.
Expect a more volatile ride than the market average; that can amplify upside, but drawdowns can come fast too.
Microsoft Corp. latest YouTube video thumbnail YouTube
Microsoft Corp.
MSFT
Latest video
Q4 FY2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.
Valuation sits in a middle zone where future upside likely depends more on quarterly execution than on multiple re-rating alone.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Market Cap
More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.
CLBT
$2.77B
Cellebrite DI Ltd.
INTC
$476.12B
Intel Corporation
MSFT
$3.59T
Microsoft Corp.
Trailing P/E
Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.
CLBT
48.0x
Cellebrite DI Ltd.
INTC
Intel Corporation
MSFT
26.9x
Microsoft Corp.
Forward P/E
Forward P/E is often a better read on what investors are paying for the next year of earnings power.
CLBT
16.9x
Cellebrite DI Ltd.
INTC
44.1x
Intel Corporation
MSFT
20.5x
Microsoft Corp.
Revenue Growth
Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.
CLBT
15.8%
Cellebrite DI Ltd.
INTC
25.4%
Intel Corporation
MSFT
17.7%
Microsoft Corp.
Earnings Growth
Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.
CLBT
-67.9%
Cellebrite DI Ltd.
INTC
Intel Corporation
MSFT
31.7%
Microsoft Corp.
Operating Margin
Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.
CLBT
5.3%
Cellebrite DI Ltd.
INTC
12.2%
Intel Corporation
MSFT
45.1%
Microsoft Corp.
Gross Margin
Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.
CLBT
83.0%
Cellebrite DI Ltd.
INTC
38.9%
Intel Corporation
MSFT
67.9%
Microsoft Corp.
Net Margin
Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.
CLBT
11.4%
Cellebrite DI Ltd.
INTC
-19.8%
Intel Corporation
MSFT
40.3%
Microsoft Corp.
Return on Equity
ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.
CLBT
12.4%
Cellebrite DI Ltd.
INTC
-10.7%
Intel Corporation
MSFT
34.0%
Microsoft Corp.
Free Cash Flow Yield
Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.
CLBT
4.5%
Cellebrite DI Ltd.
INTC
1.0%
Intel Corporation
MSFT
0.5%
Microsoft Corp.
Debt to Equity
Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.
CLBT
4.32x
Cellebrite DI Ltd.
INTC
49.00x
Intel Corporation
MSFT
29.12x
Microsoft Corp.
Current Ratio
A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.
CLBT
1.62x
Cellebrite DI Ltd.
INTC
1.60x
Intel Corporation
MSFT
1.23x
Microsoft Corp.
Beta
Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.
CLBT
1.18
Cellebrite DI Ltd.
INTC
2.24
Intel Corporation
MSFT
1.10
Microsoft Corp.
Dividend Yield
Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.
CLBT
Cellebrite DI Ltd.
INTC
Intel Corporation
MSFT
0.8%
Microsoft Corp.
Analyst Upside
Higher analyst upside suggests the Street still sees room between current price and consensus fair value.
CLBT
39.0%
Cellebrite DI Ltd.
INTC
27.5%
Intel Corporation
MSFT
17.8%
Microsoft Corp.

Related research

Non-quarter videos featuring CLBT

Special-topic videos, explainers, and shorts connected to this ticker.

All Research Sections
Shorts and Clips 2026-08-18

CLBT Stock: Cellebrite Q2 2026 Earnings - $15M Of ARR, $1.1B Of Value #Shorts

A fast Charged Alpha clip pointing viewers into the latest earnings coverage.

Episode timeline

Episode archive for CLBT

Each row is one earnings episode with every verified platform link available.

Q2 2026
Episode live
2026-08-18
Published youtube podcast complete
CLBT Stock Q2 2026: Cellebrite Earnings - $15M Of ARR, $1.1B Of Market Value
Quarterly earnings-analysis entry for Cellebrite DI Ltd.. Use the links on the right to open the video or podcast episode.